Renaissance Technologies - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$2,630,000
-36.1%
2,209,700
-3.4%
0.00%
-20.0%
Q2 2022$4,119,000
+39.7%
2,288,300
+56.7%
0.01%
+66.7%
Q1 2022$2,949,000
+78.3%
1,459,900
+139.2%
0.00%
+50.0%
Q4 2021$1,654,000
+218.1%
610,400
+423.1%
0.00%
+100.0%
Q3 2021$520,000
-58.8%
116,700
+37.5%
0.00%0.0%
Q2 2019$1,262,000
-90.7%
84,900
-67.1%
0.00%
-85.7%
Q2 2018$13,622,0000.0%258,0000.0%0.01%
-53.3%
Q1 2018$13,622,000
-55.4%
258,000
-20.9%
0.02%
-61.5%
Q2 2017$30,542,000
+212.7%
326,200
+112.6%
0.04%
+178.6%
Q1 2017$9,767,000
+167.8%
153,400
+86.8%
0.01%
+133.3%
Q4 2016$3,647,000
-13.5%
82,100
-73.3%
0.01%
-25.0%
Q2 2016$4,215,000
-57.4%
307,200
-40.4%
0.01%
-57.9%
Q1 2016$9,896,000
-16.5%
515,400
+299.8%
0.02%
-32.1%
Q3 2015$11,854,000
+1087.8%
128,900
+485.9%
0.03%
+833.3%
Q3 2014$998,000
+15.6%
22,000
+54.9%
0.00%
+50.0%
Q3 2013$863,000
-39.8%
14,200
-33.6%
0.00%
-50.0%
Q2 2013$1,433,00021,4000.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2015
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders